Infectious Diseases

The wild card that could sink stocks: What investors need to know as the Fed unwinds liquidity that had helped fuel market gains

The wild card that could sink stocks: What investors need to know as the Fed unwinds liquidity that had helped fuel market gains

Quantitative monetary easing is credited for juicing stock market returns and boosting other speculative asset values by flooding markets with liquidity as the Federal Reserve snapped up trillions of dollars in bonds during both the 2008 financial crisis and the 2020 coronavirus pandemic in particular. Investors and policy makers may be underestimating what happens as …

The wild card that could sink stocks: What investors need to know as the Fed unwinds liquidity that had helped fuel market gains Read More »

Will the Federal Reserve kill the stock-market bounce?

Bad news for stocks: Fed will be surprised how hard rate hikes hit economy, says BlackRock

Federal Reserve policy makers are about to surprise themselves — and not in a good way when it comes to stocks and other assets perceived as risky, according to analysts at BlackRock Investment Institute. BlackRock has argued that investors are dealing with a “regime shift” as the COVID-19 pandemic upended an unusual period of mild …

Bad news for stocks: Fed will be surprised how hard rate hikes hit economy, says BlackRock Read More »

Path cleared for new COVID-19 booster this week on Long Island, nationwide

Path cleared for new COVID-19 booster this week on Long Island, nationwide

A booster shot targeting the most contagious omicron subvariants should be available on Long Island this week — the first step in a nationwide immunization campaign to ward off a potential surge of COVID-19 cases this fall and winter, state officials said. The Centers for Disease Control and Prevention on Thursday approved the use of two “bivalent” booster shots that combine the original vaccine recipe with …

Path cleared for new COVID-19 booster this week on Long Island, nationwide Read More »

Dow, S&P 500 finish higher to snap 4-day losing streak ahead of August jobs report

Dow, S&P 500 finish higher to snap 4-day losing streak ahead of August jobs report

U.S. stocks finished mostly higher on Thursday as bond yields rose and another pandemic lockdown in the southwestern Chinese metropolis of Chengdu added to concerns about economic growth. The Dow Jones Industrial Average and the S&P 500 index snapped a four-day losing streak, while the Nasdaq Composite recorded its longest losing streak since February. How stocks …

Dow, S&P 500 finish higher to snap 4-day losing streak ahead of August jobs report Read More »

Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake

Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake

The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week that target the latest versions of the omicron variant but will do so without data from a study showing the shots were safe and worked in humans. Clearance of the doses, without data from human testing known as clinical trials, …

Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake Read More »

Shrinking the Fed's balance sheet sheet is not likely to be a benign process, new Jackson Hole study warns

Shrinking the Fed’s balance sheet sheet is not likely to be a benign process, new Jackson Hole study warns

“If the past repeats, the shrinking of the central bank’s balance sheet is not likely to be an entirely benign process and will require careful monitoring of the banking sector’s on-and off-balance sheet demandable liabilities” — Raghuram Rajan, former Governor of the Reserve Bank of India and former Chief Economist at the IMF The Federal …

Shrinking the Fed’s balance sheet sheet is not likely to be a benign process, new Jackson Hole study warns Read More »

Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states

Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states

Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in children 6 months to 4 years old. The companies PFE, -2.25% BNTX, -0.08% said updated analysis from 34 cases occurring at least seven days after a three-dose regimen showed 73.2% vaccine efficacy among children in that age group. The vaccine …

Pfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states Read More »

Zoom is struggling to convince consumers to pay, and the stock is sliding

Zoom is struggling to convince consumers to pay, and the stock is sliding

Zoom Video Communications Inc. is struggling to convince people to pay for its videoconferencing service in the third year of the COVID-19 pandemic, contributing to a trimmed forecast and falling stock price Monday. Zoom ZM, -2.07% executives reduced their earnings and revenue guidance for the fiscal year Monday afternoon, and Zoom Chief Financial Officer Kelly …

Zoom is struggling to convince consumers to pay, and the stock is sliding Read More »

Moderna CEO says Covid vaccines will evolve like 'an iPhone' | CNN Business

Moderna CEO says Covid vaccines will evolve like ‘an iPhone’ | CNN Business

CNN Business  —  Forget taking two to three Covid shots a year. Moderna hopes to roll out a single-dose annual booster to cover the coronavirus, the flu and another common respiratory virus within the next five years. As Covid-19 continues to mutate, Moderna will need to keep updating the vaccines that turned it into a …

Moderna CEO says Covid vaccines will evolve like ‘an iPhone’ | CNN Business Read More »

How one investor applied the lessons of the meme stocks frenzy to blockchain and NFTs

How one investor applied the lessons of the meme stocks frenzy to blockchain and NFTs

Almost two years ago, during the first winter of the COVID pandemic, Roman Tirone was introduced to the world of meme stocks. “I think I had a couple of friends reach out about them to me and I took a look,” the New York City-based investor told MarketWatch. “There was a strong community that was …

How one investor applied the lessons of the meme stocks frenzy to blockchain and NFTs Read More »